CLINICAL_TRIALS
trial_result
· 2013-06-17
Clinical Trial Update: Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia [Phase 2]
Summary
A Phase 2 safety study of GCS-100 in patients with chronic lymphocytic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: La Jolla Pharmaceutical Company | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED